Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

about

Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response

P2860

Q50318923-63806735-C347-4CCC-AF39-84149496026E Q59133970-435268CA-F28F-4EB4-B102-E485ECCFC30E

P2860

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

Item

http://www.wikidata.org/entity/Q47378147

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@en

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@nl

type

Item

label

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@en

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@nl

prefLabel

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@en

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@nl

P1476

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

@en

P2093

Kangshun Zhu

http://www.w3.org/2001/XMLSchema#string

Liteng Lin

http://www.w3.org/2001/XMLSchema#string

Mingyue Cai

http://www.w3.org/2001/XMLSchema#string

Weitong Sun

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Chen

http://www.w3.org/2001/XMLSchema#string

Zhong Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle, CDKs and cancer: a changing paradigm

Current and future treatments for hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Technologies for controlled, local delivery of siRNA

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

Hepatocellular carcinoma

Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation

Non-viral vectors for gene-based therapy.

Glypican-3: a new target for cancer immunotherapy.

Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

P304

2468-2479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7BM00866J

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xintao Shuai

Yong Wang

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106433

http://www.w3.org/2001/XMLSchema#string

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

about

P2860

P2860

Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698